News Releases

GenTegra and Neoteryx announce partnership and launch of GenTegraRNA-NEO for Mitra-VAMS microsampling of RNA

November 28, 2023

Trajan Scientific and Medical (Trajan), a global developer and manufacturer of analytical and life sciences products, today announced they have signed an agreement with GenTegra, an innovator of biological sample protection solutions, to distribute the GenTegraRNA-NEO Active Chemical Protection™ technology. GenTegra’s protection solution, designed exclusively for Trajan, can be applied to Trajan’s Neoteryx Mitra® microsampling devices based on VAMS® technology for RNA-based studies.

Thorne HealthTech and GenTegra collaborate to develop a next-generation whole blood DNA collection and extraction kit.

October 25, 2022

Thorne HealthTech, Inc. (“Thorne HealthTech” or “Thorne”) (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, announced today that it is collaborating with GenTegra, an innovator and leader of complete biological sample protection, to utilize GenTegra’s patented Active Chemical Protection™ technology and Thorne’s OneDraw™ collection device to develop a whole blood DNA collection cartridge and a complete stabilization and extraction kit.

GenTegra Announces the Launch of RNAdvantage™ for Stabilization of RNA in Fresh Tissue Samples

June 14, 2022

GenTegra LLC, an innovator of complete sample protection for biological research, announced today the launch of RNAdvantage, the latest addition to their suite of RNA stabilization products. With the launch of RNAdvantage, GenTegra products now stabilize and protect valuable RNA in fresh tissue samples, purified liquid RNA using RNAssure™, and ambient shipping and long-term storage with GenTegraRNA™.

GenTegra Launches new GenTegra RNAssure™ for immediate protection of RNA following purification

October 15, 2021

As soon as RNA is purified and eluted from the column or removed from the magnetic beads any trace of RNase contamination will begin to degrade the RNA.

Novel SARS CoV-2 Saliva Collection Devices Address COVID-19 Testing Challenges, Improving Lab Efficiency and PCR Test Performance

January 26, 2021

GenTegra, LLC, announced today a study on the development and characterization of two novel COVID-19 saliva sample collection tube devices. The publication is posted on medRxiv, the pre-print server for health sciences.

GenTegra, LLC Announces New SARS-CoV-2 Sample Stabilization and Transport Products to Facilitate Expansion of COVID-19 Testing

June 16, 2020

Gentegra announce two new viral stabilization products, GenTegra® GTR-STM™ and GenTegra® GTR-VTM™. Products address sample transport and stability challenges associated with SARS-CoV-2 samples, and…

Exclusive Worldwide Distribution Agreement with ITSI Bioscience LLC.

October 29, 2019

Exclusive Worldwide distribution agreement with ITSI Biosciences expands Gentegra’s customer reach…

GenTegra LLC $2.8M SBIR Grant for RNA Collection Cards

April 25, 2019

GenTegra awarded a Phase IIb Small Business Innovation Research (SBIR) grant for $2.8M from NIAID. This three-year grant will fund the development of filter paper technologies for collection and stabilization of RNA …

GenTegra Launches Ahlstrom GenSaver 2.0 Forensic Card

November 14, 2017

Antimicrobial properties included to provide high quality protection of the DNA for >20 years, an important requirement for the forensic market…

GenTegra, LLC $1.8M SBIR Grant for RNA

March 15, 2017

The two-year grant will fund the development of filter paper technology for the collection and stabilization of RNA virus in whole blood and plasma at ambient temperatures …

Ahlstrom GenSaver™ Collection Card for Dried Blood Spots (DBS)

February 2, 2016

GenTegra LLC and Ahlstrom have launched a new DBS collection card that provides superior protection for the DNA in DBS. Now stable without freezing for >20 years…

Texas A&M AgriLife Research and GenTegra LLC are Awarded Contract Continuation

November 2, 2015

Gentegra announces two new viral stabilization products, GenTegra® GTR-STM™ and GenTegra® GTR-VTM™. Products address sample transport and stability challenges associated with SARS-CoV-2 samples, and…

Tasso and GenTegra Simplify Blood Draws, Awarded $3M Expansion

Tasso, Inc., a medtech start-up developing the HemoLink™, a small disposable device to simplify blood sampling, has secured an additional $2.9M in grant funding to advance its HemoLink technology…

Protect Your RNA Samples Immediately, and for All its Tomorrows

March 21, 2014

GenTegra LLC, Pleasanton, CA, announces launch of GenTegra®-RNA dry Bulk. GenTegra-RNA is groundbreaking technology for the stabilization, transport and storage of purified RNA….

Translate »